Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lasser MD, D. M.
Right arrow Articles by Wilhelmsen MD PhD, K. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lasser MD, D. M.
Right arrow Articles by Wilhelmsen MD PhD, K. C.
NEUROLOGY 1994;44:1083
© 1994 American Academy of Neurology

Turcot's syndrome

Evidence for linkage to the adenomatous polyposis coli (APC) locus

Daniel M. Lasser MD, Darryl C. DeVivo MD, James Garvin, MD PhD and Kirk C. Wilhelmsen MD PhD

Departments of Neurology (Dr. Wilhelmsen) and Obstetrics and Gynecology (Dr. Lasser), the Division of Pediatric Neurology (Dr. DeVivo), and the Department of Pediatrics (Dr. Garvin), College of Physicians and Surgeons of Columbia University, New York, NY.

Objective: To investigate the possibility that neuroepithelial tumors in Turcot's syndrome are caused by pleiotropic mutations in the gene for adenomatous polyposis coli (APC), a tumor-suppressor gene implicated in colonic cancer.

Methods: We studied the inheritance patterns of genetic markers for the chromosome 5q21 region in 12 members of a Turcot's syndrome kindred with five affected members. We performed linkage analysis to detect linkage between the disease phenotype and DNA markers.

Results: Marker D5S346, located 30 to 70 kilobases from the APC locus, showed evidence highly suggestive of linkage to the disease phenotype (lod score = 1.92).

Conclusions: The data provide evidence that the tumor-suppressor gene implicated in APC and sporadic colon cancers may also cause malignant neuroepithelial tumors in Turcot's syndrome.

Address correspondence and reprint requests to Dr. Kirk C. Wilhelmsen, Department of Neurology, Columbia University School of Medicine, 620 West 168th Street, New York, NY 10032.

Supported by the Herbert Irving Assistant Professorship, the Klingenstein Fellowship, and the Parkinson's Disease and Myoclonus Foundations (K.C.W.), and by the American Gynecological and Obstetrical Society Foundation Award and the Sloane-Rosen Research Scholarship (D.M.L.).

Received August 5, 1993. Accepted for publication in final form December 22, 1993.




This article has been cited by other articles:


Home page
Genes Dev.Home page
P. Polakis
Wnt signaling and cancer
Genes & Dev., August 1, 2000; 14(15): 1837 - 1851.
[Full Text]


Home page
NEJMHome page
W. H. Yong, C. Raffel, A. von Deimling, D. N. Louis, H. P. Rutz, and T. Kikuchi
The APC Gene in Turcot's Syndrome
N. Engl. J. Med., August 24, 1995; 333(8): 524 - 524.
[Full Text]


Home page
NEJMHome page
S. R. Hamilton, B. Liu, R. E. Parsons, N. Papadopoulos, J. Jen, S. M. Powell, A. J. Krush, T. Berk, Z. Cohen, B. Tetu, et al.
The Molecular Basis of Turcot's Syndrome
N. Engl. J. Med., March 30, 1995; 332(13): 839 - 847.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by AAN Enterprises, Inc.